Foley Hoag advised Applied Genetic Technologies Corporation (“AGTC”) on the deal. Applied Genetic Technologies Corporation (Nasdaq: AGTC) (“AGTC”), a clinical-stage biotechnology company focused on the development...
You must be a Standard 1 Year member to access this content.
Foley Hoag LLP advised Lantheus Holdings, Inc. on the deal. Lantheus Holdings, Inc. (NASDAQ: LNTH) announced a Rule 144A offering of $575 million aggregate principal amount...
You must be a Standard 1 Year member to access this content.
Foley Hoag LLP represented The Valens Company on the deal. The Valens Company (TSX: VLNS; Nasdaq: VLNS), a leading manufacturer of cannabis products, announced its underwritten “bought...
You must be a Standard 1 Year member to access this content.
Stoic Advisory Inc. and Solidum Capital Advisors are acting as financial advisor to Cresco Labs. A.G.P./Alliance Global Partners provided a fairness opinion to Cresco Labs’ Board...
You must be a Standard 1 Year member to access this content.
Foley Hoag advised The Valens Company on the deal. The Valens Company Inc. (“Valens”), a leading manufacturer of cannabis products, gained approval for an application to list...
You must be a Standard 1 Year member to access this content.
Foley Hoag advised Trulieve Cannabis Corp. on the deal. Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) closed its previously announced private placement of 8% Senior Secured Notes...
You must be a Standard 1 Year member to access this content.
Foley Hoag LLP advised Trulieve Cannabis Corp. on the deal. Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) annunced its marketed public offering of 5,000,000 subordinate voting shares...
You must be a Standard 1 Year member to access this content.
Foley Hoag LLP advised Cultivate Holdings on the deal. Cultivate Holdings executing a definitive agreement to sell 100% of its business to Cresco Labs (CSE:CL) (OTCQX:CRLBF),...
You must be a Standard 1 Year member to access this content.
